Skip to Content
Merck
  • Extracellular Acidosis Promotes Metastatic Potency via Decrease of the BMAL1 Circadian Clock Gene in Breast Cancer.

Extracellular Acidosis Promotes Metastatic Potency via Decrease of the BMAL1 Circadian Clock Gene in Breast Cancer.

Cells (2020-04-23)
Yong-Jin Kwon, Eun-Bi Seo, Sun-Ho Kwon, Song-Hee Lee, Seul-Ki Kim, Sang Ki Park, Kyungjin Kim, SaeGwang Park, In-Chul Park, Jong-Wan Park, Sang-Kyu Ye
ABSTRACT

Circadian oscillation is an essential process that influences many physiological and biological mechanisms and a decrease of circadian genes is associated with many diseases such as cancer. Despite many efforts to identify the detailed mechanism for decreasing circadian genes and recovering reduced circadian genes in cancer, it is still largely unknown. We found that BMAL1 was reduced in tumor hypoxia-induced acidosis, and recovered by selectively targeting acidic pH in breast cancer cell lines. Surprisingly, BMAL1 was reduced by decrease of protein stability as well as inhibition of transcription under acidosis. In addition, melatonin significantly prevented acidosis-mediated decrease of BMAL1 by inhibiting lactate dehydrogenase-A during hypoxia. Remarkably, acidosis-mediated metastasis was significantly alleviated by BMAL1 overexpression in breast cancer cells. We therefore suggest that tumor hypoxia-induced acidosis promotes metastatic potency by decreasing BMAL1, and that tumor acidosis could be a target for preventing breast cancer metastasis by sustaining BMAL1.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Sodium oxamate, ≥98%
Sigma-Aldrich
MISSION® esiRNA, targeting human LDHA